- All sections
- C - Chemistrymetallurgy
- C07K - Peptides
- C07K 14/35 - Peptides having more than 20 amino acidsGastrinsSomatostatinsMelanotropinsDerivatives thereof from bacteria from Mycobacteriaceae (F)
Patent holdings for IPC class C07K 14/35
Total number of patents in this class: 536
10-year publication summary
|
36
|
43
|
30
|
28
|
27
|
34
|
26
|
29
|
38
|
22
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| The UAB Research Foundation | 647 |
22 |
| International AIDS Vaccine Initiative, Inc. | 63 |
16 |
| Glaxosmithkline Biologicals S.A. | 1652 |
15 |
| University of Washington | 2378 |
15 |
| Altor BioScience, LLC | 76 |
15 |
| Longhorn Vaccines and Diagnostics, LLC | 90 |
12 |
| Oxford NanoPore Technologies Limited | 270 |
11 |
| Revolo Biotherapeutics Limited | 24 |
11 |
| Glaxo Group Limited | 4121 |
10 |
| Wisconsin Alumni Research Foundation | 3890 |
10 |
| The Regents of the University of California | 20268 |
9 |
| The General Hospital Corporation | 4797 |
9 |
| HAV Vaccines Limited | 11 |
9 |
| Institut Pasteur | 783 |
8 |
| Qiagen Sciences, LLC | 187 |
8 |
| President and Fellows of Harvard College | 6030 |
7 |
| Illumina, Inc. | 3417 |
7 |
| Statens Serum Institut | 88 |
6 |
| Oxford NanoPore Technologies plc | 354 |
6 |
| Centre National de La Recherche Scientifique | 10666 |
5 |
| Other owners | 325 |